|
|
|
Insider
Information: |
Scadden David |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
240,270 |
|
Indirect Shares
|
580,499 |
|
|
Direct
Value |
$556,347 |
|
|
Indirect Value
|
$406,117 |
|
|
Total
Shares |
820,769 |
|
|
Total
Value |
$962,464 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2023-06-21 |
12,095 |
|
0 |
Premium* |
|
Dianthus Therapeutics Ord Shs |
DNTH |
Director |
2018-06-25 |
228,175 |
2018-06-25 |
580,499 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2023-06-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,975 |
12,095 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2022-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,585 |
7,120 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2021-05-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,686 |
5,535 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2020-05-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,878 |
3,849 |
0 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2019-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,400 |
1,971 |
0 |
- |
|
DNTH |
Dianthus Therapeutics Ord... |
Director |
|
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
28,076 |
221,575 |
0 |
- |
|
DNTH |
Dianthus Therapeutics Ord... |
Director |
|
2018-06-25 |
4 |
B |
$15.00 |
$99,000 |
D/D |
6,600 |
228,175 |
2.39 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2018-03-16 |
4 |
B |
$83.44 |
$16,688 |
D/D |
200 |
571 |
2.39 |
- |
|
AGIO |
Agios Pharmaceuticals Inc |
Director |
|
2017-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
371 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|